Hepatica
Hepatica
Hepatica is a traditional plant whose specific medicinal uses are not well-documented. It has been studied for its potential benefits, particularly in treating liver conditions such as cirrhosis. A controlled trial showed that TCBZ at 10 mg/kg had a therapeutic efficacy of 92.31% in humans; however, results from a smaller study in sheep suggested possible treatment failure due to resistance, indicating variability in outcomes. In horses, the prevalence of gastrointestinal parasites was found to be high (88.80%), with fifteen species identified, but no direct link to hepatica's use was established. A pharmacist-led intervention reduced unplanned hospitalizations by 48% in patients with liver cirrhosis, though there were no significant differences noted for all-cause mortality. No major safety issues or drug interactions have been recorded for hepatica.
- Best evidence
- B
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- A high percentage of patients with cirrhosis received potentially inappropriate medications, with half of pharmacist recommendations accepted.
- TCBZ at 10 mg/kg showed a therapeutic efficacy of 92.31% in humans, while a controlled trial in sheep indicated potential treatment failure due to possible resistance.
- The overall prevalence of gastrointestinal parasites was 88.80% among horses in the district of Abidjan, with fifteen species identified.
- The study found that a pharmacist-led intervention reduced unplanned hospitalizations by 48% in patients with liver cirrhosis, though no significant differences were seen in all-cause mortality.
Frequently asked questions
What is Hepatica?
Hepatica (Hepatica) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Hepatica?
4 sourced findings are recorded for Hepatica; the strongest carries evidence grade B. For example: A high percentage of patients with cirrhosis received potentially inappropriate medications, with half of pharmacist recommendations accepted.
How strong is the evidence for Hepatica?
The strongest finding for Hepatica carries evidence grade B — moderate evidence. Grades run A (strongest) to D (preliminary or traditional).
Is Hepatica safe? What are the side effects?
No major safety issues are recorded for Hepatica in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Hepatica interact with medications?
No drug interactions are recorded for Hepatica in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Hepatica?
Hepatica is also known as: печёночница.
Is Hepatica a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Efficacy of two triclabendazole regimens for treating human chronic fasciolosis and a controlled efficacy trial in sheep using human-isolate metacercariae in Cajamarca, Peru. literature abstract metadata
- T2 Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis. literature abstract metadata
- T2 Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care. literature abstract metadata
- T2 Prevalence of gastrointestinal parasites in horses in the district of Abidjan, Ivory Coast. literature abstract metadata